Suppr超能文献

针对流感嗜血杆菌对选定头孢菌素类抗生素纸片扩散法药敏试验修订质量控制限度的制定及一种新对照菌株的描述

Development of revised quality control limits for disk diffusion susceptibility tests of selected cephem antibiotics with Haemophilus influenzae and description of a new control strain.

作者信息

Jorgensen J H, Barry A L, Doern G V, Ferraro M J, Murray P R

机构信息

Department of Pathology, University of Texas Health Science Center, San Antonio 78284-7750.

出版信息

J Clin Microbiol. 1992 Aug;30(8):2029-32. doi: 10.1128/jcm.30.8.2029-2032.1992.

Abstract

Inconsistent quality control results in disk diffusion testing of cefaclor, cefamandole, cefonicid, and cefuroxime with Haemophilus influenzae ATCC 49247 and Haemophilus test medium (HTM) prompted a search for an alternative control strain that would provide more reliable results. A five-laboratory study was conducted to evaluate two candidate H. influenzae strains as possible alternatives to the aforementioned strain. Repetitive testing of the candidate strains and H. influenzae ATCC 49247 over several days with a total of six different lots of HTM documented consistent performance of the two candidate strains and confirmed inconsistent results for some of the antibiotics with H. influenzae ATCC 49247. In particular, certain lots of HTM failed to yield cefaclor and cefamandole zone sizes within the quality control range advocated by the National Committee for Clinical Laboratory Standards. Because of the greater consistency offered by the new strains, one was selected (now designated H. influenzae ATCC 49766) to be recommended for routine quality control testing of cefaclor, cefamandole, cefonicid, cefuroxime, and the related carbacephem loracarbef. The new control strain and zone size ranges proposed here have been approved by the National Committee for Clinical Laboratory Standards in place of the previously recommended strain and zone size limits for testing of these five cephem antibiotics.

摘要

使用流感嗜血杆菌ATCC 49247和嗜血杆菌测试培养基(HTM)对头孢克洛、头孢孟多、头孢尼西和头孢呋辛进行纸片扩散试验时,质量控制结果不一致,促使人们寻找一种能提供更可靠结果的替代对照菌株。开展了一项五实验室研究,以评估两种候选流感嗜血杆菌菌株作为上述菌株的可能替代物。在几天内,使用总共六个不同批次的HTM对候选菌株和流感嗜血杆菌ATCC 49247进行重复测试,记录了两种候选菌株的一致表现,并证实了某些抗生素与流感嗜血杆菌ATCC 49247的结果不一致。特别是,某些批次的HTM未能使头孢克洛和头孢孟多的抑菌圈大小在临床实验室标准委员会倡导的质量控制范围内。由于新菌株具有更高的一致性,选择了一种(现指定为流感嗜血杆菌ATCC 49766)推荐用于头孢克洛、头孢孟多、头孢尼西、头孢呋辛以及相关碳头孢烯类药物氯碳头孢的常规质量控制测试。这里提出的新对照菌株和抑菌圈大小范围已得到临床实验室标准委员会的批准,以取代先前推荐的用于这五种头孢菌素类抗生素测试的菌株和抑菌圈大小限制。

相似文献

引用本文的文献

本文引用的文献

7
In vitro activities of LY163892, cefaclor, and cefuroxime.LY163892、头孢克洛和头孢呋辛的体外活性。
Antimicrob Agents Chemother. 1988 Jan;32(1):131-3. doi: 10.1128/AAC.32.1.131.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验